Corcept (CORT) insider resale notice: 20,000 shares via option exercise (06/02/2026)
Rhea-AI Filing Summary
Corcept Therapeutics Inc. reported proposed sales of common stock by an affiliate under a Form 144 notice. The filing lists a 20,000-share sale associated with a stock option exercise on 06/02/2026 and several prior dispositions in March–May 2026.
The filings show prior reported sales of 20,000 shares on 04/08/2026 for $819,453.00, 8,233 shares on 03/04/2026 for $296,346.00, 11,767 shares on 03/20/2026 for $423,707.00, and 20,000 shares on 05/06/2026 for $1,036,522.00. The broker listed is Stifel Nicolaus & Company Inc.
Positive
- None.
Negative
- None.
Insights
Form 144 notice documents proposed resale of registered shares by an affiliate.
The filing lists proposed sales tied to a stock option exercise and multiple prior dispositions with broker identification. Form 144 is a notice used to satisfy resale reporting requirements under the securities laws.
Timing and cash‑flow treatment are shown as Cash for the 06/02/2026 entry; subsequent public filings will show whether the sales occurred and their exact mechanics.